Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds.
Alessandro Garneri has spent nearly two decades shaping the botanical foundations of some of the world’s most recognized ...
Fractal Analytics IPO listing is on February 16, with shares credited to demat accounts today. The IPO, which saw strong QIB interest, closed 2.7x subscribed, with a price band of ₹857 to ₹900 per ...
HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...
FUJIFILM Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, ...
Designed specifically for bioreactor-scale workflows, the Krakatoa (R) K500 requires less than 15 minutes of hands-on time and produces up to 500 liters in less than three hours. Two standard pod ...
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has issued a Material Qualification Certificate for ELAREM™ Ultimate-FD PLUS (GMP ...
Made Scientific, a leading clinical- and commercial-enabling cell therapy contract development and manufacturing organization ...
Discover how Catalent's Rapid Antibody platform delivers GMP drug substance in 8 months, accelerating mAb development from gene construct to IND readiness.
Balancing in-house expertise and external support is key for CGT innovators navigating GMP production and commercialization.
Fractal Analytics IPO: Fractal Analytics' IPO opened today. It will remain open until February 11, 2026. The company's IPO size is ₹2,833.90 crore. An AI-related company's IPO is set to hit the market ...
“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results